Literature DB >> 7437251

Fatty acids modulation of meal-induced variations in diazepam free fraction.

C A Naranjo, E M Sellers, V Khouw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437251      PMCID: PMC1430077          DOI: 10.1111/j.1365-2125.1980.tb01763.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  The displacing effect of a fatty acid on the binding of diazepam to human serum albumin.

Authors:  E Tsutsumi; T Inaba; W A Mahon
Journal:  Biochem Pharmacol       Date:  1975-07-15       Impact factor: 5.858

2.  Circular dichroism studies on the inhibiting effect of oleic acid on the binding of diazepam to human serum albumin.

Authors:  T Sjödin
Journal:  Biochem Pharmacol       Date:  1977-11-15       Impact factor: 5.858

3.  Food intake and plasma binding of diazepam.

Authors:  U Klotz; H K Antonin; P Bieck
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

4.  Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction.

Authors:  C A Naranjo; E M Sellers; H G Giles; J G Abel
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

5.  Plasma protein binding of diazepam after a single dose of sodium oleate.

Authors:  W A Colburn; M Gibaldi
Journal:  J Pharm Sci       Date:  1978-06       Impact factor: 3.534

6.  Diurnal fluctuations in triglyceride, free fatty acids, and insulin during sucrose consumption and insulin infusion in man.

Authors:  P J Barter; K F Carroll; P J Nestel
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

7.  Unchanged protein binding and the increase of serum diazepam levels after food intake.

Authors:  K Korttila; L Kangas
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-02

8.  Inter- and intrasubject variation in diazepam free fraction.

Authors:  J G Abel; E M Sellers; C A Naranjo; J Shaw; D Kadar; M K Romach
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

9.  Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis.

Authors:  G Schlierf; E Dorow
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

10.  Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.

Authors:  U Klotz; K H Antonin; P R Bieck
Journal:  J Pharmacol Exp Ther       Date:  1976-10       Impact factor: 4.030

View more
  6 in total

1.  Unaltered serum propranolol binding by meal-induced variations in fatty acids.

Authors:  C A Naranjo; E M Sellers; V Khouw
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

2.  Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans.

Authors:  R Jochemsen; J J Hogendoorn; J Dingemanse; J Hermans; J K Boeijinga; D D Breimer
Journal:  J Pharmacokinet Biopharm       Date:  1982-06

3.  Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses.

Authors:  K Aranko; T Seppälä; J Pellinen; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.

Authors:  F J Rowell; S M Hui; A F Fairbairn; D Eccleston
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 5.  Free drug metabolic clearance in elderly people.

Authors:  Jennifer M Butler; Evan J Begg
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

6.  First-in-Human Single-Ascending-Dose, Multiple-Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy.

Authors:  Eva Tiecke; Maurizio Rainisio; Theodor Guentert; Stephan Müller; Liat Hochman; Eli Kaplan; Sara Mangialaio
Journal:  Clin Pharmacol Drug Dev       Date:  2022-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.